Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Clinical trial NCT00097500 · COMPLETED

Trial details

NCT number: NCT00097500
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2004-09-01
Primary completion: 2009-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.